« Previous Abstract"Effect of chirality, release rate, and host volatiles on response of Tetropium fuscum (F.), Tetropium cinnamopterum Kirby, and Tetropium castaneum (L.) to the aggregation pheromone, fuscumol"    Next AbstractImpact of stressors in the aviation environment on xenobiotic dosimetry in humans: physiologically based prediction of the effect of barometric pressure or altitude »

Toxicol Sci

Title:		Ethyl acrylate risk assessment with a hybrid computational fluid dynamics and physiologically based nasal dosimetry model
Author(s):		Sweeney LM; Andersen ME; Gargas ML;
Address:		"The Sapphire Group, Dayton, Ohio 45431, USA. LMS29@alumni.cwru.edu"
Journal Title:		Toxicol Sci
Year:		2004
Volume:		20040331
Issue:		2
Page Number:		394 - 403
DOI:		10.1093/toxsci/kfh116
ISSN/ISBN:		1096-6080 (Print) 1096-0929 (Linking)
Abstract:		"Cytotoxicity in the nasal epithelium is frequently observed in rodents exposed to volatile organic acids and esters by inhalation. An interspecies, hybrid computational fluid dynamics and physiologically based pharmacokinetic (CFD-PBPK) dosimetry model for inhaled ethyl acrylate (EA) is available for estimating internal dose measures for EA, its metabolite acrylic acid (AA), and EA-mediated reductions in tissue glutathione (GSH). Nasal tissue concentrations of AA were previously used as the dose metric for a chronic Reference Concentration (RfC) calculation with this compound. However, EA was more toxic than expected, based on calculated tissue AA concentrations. Unlike AA, EA causes depletion of tissue GSH. We have developed an RfC for EA using tissue GSH depletion in the olfactory epithelium as the primary measure of nasal tissue dose. The hybrid CFD-PBPK model was refined to improve the accuracy of simulations for GSH in rat olfactory tissues. This refined model was used to determine the concentration for continuous human exposures to EA predicted to reduce nasal GSH levels to the same extent as seen in rats exposed to EA at the no-observed-effect level (NOEL). Importantly, AA concentrations in the human nasal olfactory epithelium at the proposed chronic RfC were predicted to be lower than the AA concentrations estimated in the rat at the NOEL. Thus, a chronic RfC based on maintaining GSH in the human nasal olfactory epithelium at levels equivalent to the rat NOEL would also provide an adequate margin of safety with respect to AA concentrations in nasal tissues"
Keywords:		"Acrylates/pharmacokinetics/*toxicity Animals Computer Simulation Glutathione/metabolism Humans Inhalation Exposure Models, Biological Nasal Mucosa/chemistry/*drug effects/metabolism No-Observed-Adverse-Effect Level Risk Assessment;"
Notes:		"MedlineSweeney, Lisa M Andersen, Melvin E Gargas, Michael L eng Research Support, Non-U.S. Gov't 2004/04/02 Toxicol Sci. 2004 Jun; 79(2):394-403. doi: 10.1093/toxsci/kfh116. Epub 2004 Mar 31"